EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Raffles Medical Group's enterprise value is €1,147.0 Mil.
Raffles Medical Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €112.5 Mil. Therefore, Raffles Medical Group's EV-to-EBITDA for today is 10.20.
The historical rank and industry rank for Raffles Medical Group's EV-to-EBITDA or its related term are showing as below:
FRA:02M1'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.63 Med: 18.63 Max: 29.25
Current: 10.25
During the past 13 years, the highest EV-to-EBITDA of Raffles Medical Group was 29.25. The lowest was 7.63. And the median was 18.63.
FRA:02M1's EV-to-EBITDA is ranked better than 60.82% of 462
companies
in the Healthcare Providers & Services industry
Industry Median: 12.85
vs FRA:02M1: 10.25
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Raffles Medical Group EV-to-EBITDA Historical Data
The historical data trend for Raffles Medical Group's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Raffles Medical Group's EV-to-EBITDA
For the Medical Care Facilities subindustry, Raffles Medical Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Raffles Medical Group's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Raffles Medical Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Raffles Medical Group's EV-to-EBITDA falls into.
Raffles Medical Group's current Enterprise Value is €1,147.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Raffles Medical Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €112.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Raffles Medical Group (FRA:02M1) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Raffles Medical Group's PE Ratio for today is calculated as:
Raffles Medical Group's share price for today is €0.67.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Raffles Medical Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €0.033.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Raffles Medical Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Raffles Medical Group (FRA:02M1) Business Description
Raffles Medical Group Ltd is an integrated private healthcare provider in Asia with operations in Singapore, China, Japan, Vietnam, and Cambodia. The company owns and operates a tertiary hospital, a network of medical and dental clinics, insurance services, Japanese and Traditional Chinese Medicine clinics, and a consumer healthcare division. The Hospital services segment provides medical services and operates hospitals, medical laboratories, and imaging centers. The Healthcare Services segment operates medical clinics and other general medical services, provides health insurance, trades pharmaceutical and nutraceutical products and diagnostic equipment, and provides management and consultancy services. The Investment holding segment involves investment in properties.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:02M1 has been successfully added to your 